CAS 1019206-88-2 appears in our catalog under these names: Regorafenib Monohydrate, Regorafenib monohydrate, Regorafenib monohydrate/ 99.47% (existing batch purity), Regorafenib monohydrate 98%, Regorafenib. Offered by: Mikromol, GLPBio, TargetMol, Biosynth, Ambeed. Available pack sizes: 250mg, 10mg, 100mg, 200mg, 10mM (in 1ml dmso), 50mg, 5mg, 25mg.
Regorafenib hydrate is a hydrate that is the monohydrate form of anhydrous regorafenib. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and a hepatotoxic agent. It contains a regorafenib.
Source: ChEBI
| Molecular formula | C21H17ClF4N4O4 |
|---|---|
| Molecular weight | 500.8 g/mol |
| IUPAC name | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;hydrate |
| InChIKey | ZOPOQLDXFHBOIH-UHFFFAOYSA-N |
| SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O |
Computed by PubChem (NCBI)